Integrated Use of PD-1 Inhibition and Transarterial Chemoembolization for Hepatocellular Carcinoma: Evaluation of Safety and Efficacy in a Retrospective, Propensity Score-Matched Study
Author
Muzaffar, Mahvish; Marinelli, Brett
Date
2022
Citation:
APA:
Muzaffar, Mahvish, & Marinelli, Brett. (January 2022).
Integrated Use of PD-1 Inhibition and Transarterial Chemoembolization for Hepatocellular Carcinoma: Evaluation of Safety and Efficacy in a Retrospective, Propensity Score-Matched Study.
,
(),
-
. Retrieved from
http://hdl.handle.net/10342/12171
MLA:
Muzaffar, Mahvish, and Marinelli, Brett.
"Integrated Use of PD-1 Inhibition and Transarterial Chemoembolization for Hepatocellular Carcinoma: Evaluation of Safety and Efficacy in a Retrospective, Propensity Score-Matched Study". .
. (),
January 2022.
April 18, 2024.
http://hdl.handle.net/10342/12171.
Chicago:
Muzaffar, Mahvish and Marinelli, Brett,
"Integrated Use of PD-1 Inhibition and Transarterial Chemoembolization for Hepatocellular Carcinoma: Evaluation of Safety and Efficacy in a Retrospective, Propensity Score-Matched Study," , no.
(January 2022),
http://hdl.handle.net/10342/12171 (accessed
April 18, 2024).
AMA:
Muzaffar, Mahvish, Marinelli, Brett.
Integrated Use of PD-1 Inhibition and Transarterial Chemoembolization for Hepatocellular Carcinoma: Evaluation of Safety and Efficacy in a Retrospective, Propensity Score-Matched Study. .
January 2022;
():
.
http://hdl.handle.net/10342/12171. Accessed
April 18, 2024.
Collections